Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy

NCT00866554 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Erectile Dysfunction
Lower Urinary Tract Symptoms

Interventions

DRUG: administration of a LHRH agonist and Bicalutamide
DRUG: administration of Bicalutamide, Dutasteride and Tamoxifen

Sponsor

CHU de Quebec-Universite Laval

Collaborators

[object Object]